Jenner Institute University of Oxford
Sarah Gilbert (Ph.D.) joined the Nuffield Department of Medicine at Oxford University in 1994 and became part of the Jenner Institute (within NDM) when it was founded in 2005. Her chief research interest is the development of viral vectored vaccines that work by inducing strong and protective Tand B-cell responses. She leads the Jenner Institute program in influenza vaccine development and now also works on vaccines for many different emerging pathogens, including Nipah, MERS, Lassa and CCHF. Working with colleagues in the Jenner Institute research labs, the Clinical Biomanufacturing Facility and Centre for Clinical Vaccinology and Tropical Medicine, all situated on the Old Road Campus in Oxford, she is able to take novel vaccines from design to clinical development, with a particular interest in the rapid transfer of vaccines into GMP manufacturing and first in human trials. She is the Oxford Project Leader for ChAdOx1nCoV-19.